The impact of newborn screening and earlier intervention on the clinical course of cystic fibrosis

F Nicole Dijk; Dominic A Fitzgerald

doi:10.1016/j.prrv.2012.05.003

The impact of newborn screening and earlier intervention on the clinical course of cystic fibrosis

Paediatr Respir Rev. 2012 Dec;13(4):220-5. doi: 10.1016/j.prrv.2012.05.003. Epub 2012 Jul 10.

Authors

F Nicole Dijk¹, Dominic A Fitzgerald

Affiliation

¹ Department of Respiratory Medicine, The Children's Hospital at Westmead, Sydney, Australia.

PMID: 23069119
DOI: 10.1016/j.prrv.2012.05.003

Abstract

Cystic fibrosis is a life-limiting condition which is readily diagnosed in the vast majority of cases on newborn screening [NBS]. A diagnosis made on newborn screening translates into earlier initiation of therapies, improved growth, better lung function into the adult years and culminates in better survival.

Publication types

Review

MeSH terms

Cystic Fibrosis / diagnosis*
Cystic Fibrosis / mortality
Cystic Fibrosis / therapy*
Humans
Infant, Newborn
Neonatal Screening*